INVO Bioscience Inc

NASDAQ:INVO   1:10:53 PM EDT
3.30
+0.02 (+0.49%)
Earnings Announcements

Invo Bioscience Reports Q2 2021 Financial And Operating Results

Published: 08/16/2021 21:19 GMT
INVO Bioscience Inc (INVO) - Invo Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0.88 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.